Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates

Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).   Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 08/12/2019 10:00 AM EDT The study is part of the emergency response to an ongoing Ebola outbreak in the North Kivu and Ituri Provinces. Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health. NIH…Turning Discovery Into Health®      This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612